Emerging drugs in peripheral arterial disease

Expert Opinion on Emerging Drugs
Nirman TulsyanVikram S Kashyap

Abstract

Peripheral arterial disease (PAD) is the manifestation of atherosclerotic occlusion within a peripheral vascular bed. This can occur in any noncoronary arterial bed, but PAD most commonly refers to atherosclerosis in the aorto-iliac system and infrainguinal vessels that lead to symptoms in the lower extremities. The disease most often becomes clinically apparent in elderly individuals, commonly presenting as intermittent claudication. More advanced, or multisegmental disease, may present with ischaemic rest pain or tissue loss. Although the limb manifestations of PAD can be disabling, PAD is also a marker of coronary or cerebrovascular atherosclerosis. In fact, approximately 80% of mortality in PAD patients is secondary to a cardiovascular event. In accordance with this, initial medical management of this disease focuses on preventative and risk reduction strategies to minimise the risk of cardiovascular morbidity and mortality. At present, the majority of recommendations with respect to risk reduction therapy in PAD patients are extrapolated from the coronary and cerebrovascular literature. Limb-directed therapy in PAD intends to minimise symptoms and serve as an adjunct to surgical intervention. However, existing data on the ...Continue Reading

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Jul 1, 1991·Circulation·V Ralevic, G Burnstock
Feb 6, 1992·The New England Journal of Medicine·M H CriquiD Browner
Mar 1, 1991·The British Journal of Surgery·H BarrR B Galland
Feb 1, 1990·The British Journal of Surgery·D C BerridgeB R Hopkinson
Jan 1, 1985·Journal of the American Geriatrics Society·W B Kannel, D L McGee
Sep 27, 1995·JAMA : the Journal of the American Medical Association·A W Gardner, E T Poehlman
Sep 1, 1994·American Journal of Epidemiology·S J BowlinU Goldbourt
Feb 1, 1994·Journal of Vascular Surgery·J StroughtonV J Marder
Feb 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·D H Blankenhorn, H N Hodis
Jan 1, 1996·Journal of Vascular Surgery·J G RegensteinerW R Hiatt
Apr 1, 1996·International Journal of Epidemiology·H E StoffersJ A Knottnerus
Jun 11, 1997·JAMA : the Journal of the American Medical Association·I M GrahamG Andria
Nov 18, 1997·Annals of Vascular Surgery·M Matas DocampoM Moreiras Barreiro
Mar 4, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·W T MeijerD E Grobbee
Jun 5, 1998·JAMA : the Journal of the American Medical Association·R S Rosenson, C C Tangney
Jan 8, 1999·Annals of Vascular Surgery·M R Nehler, W R Hiatt
Oct 12, 1999·Circulation·M J Quinn, D J Fitzgerald
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Nov 7, 2000·The American Journal of Medicine·D L DawsonD E Strandness

❮ Previous
Next ❯

Citations

May 27, 2009·Clinical Rheumatology·Romy Beatriz Christmann de SouzaClaudia Teresa Lobato Borges
Nov 21, 2013·Modern Rheumatology·Ya-Nan WanJing Wang
Nov 2, 2011·Acta Cirúrgica Brasileira·Carlos Eli PiccinatoEdwaldo Edner Joviliano
Nov 4, 2020·VASA. Zeitschrift für Gefässkrankheiten·Christoph LangeIvo Buschmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.